Annual SGA
$74.49 M
+$2.34 M+3.25%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual SGA is $74.49 million, with the most recent change of +$2.34 million (+3.25%) on December 31, 2023.
- During the last 3 years, OCUL annual SGA has risen by +$25.02 million (+50.56%).
- OCUL annual SGA is now at all-time high.
Performance
OCUL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$22.81 M
-$6.86 M-23.11%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly SGA is $22.81 million, with the most recent change of -$6.86 million (-23.11%) on September 30, 2024.
- Over the past year, OCUL quarterly SGA has increased by +$4.91 million (+27.43%).
- OCUL quarterly SGA is now -23.11% below its all-time high of $29.66 million, reached on June 30, 2024.
Performance
OCUL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.11 B
-$174.34 M-5.94%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM SGA is -$3.11 billion, with the most recent change of -$174.34 million (-5.94%) on September 30, 2024.
- Over the past year, OCUL TTM SGA has dropped by -$3.19 billion (-4185.29%).
- OCUL TTM SGA is now -5015.01% below its all-time high of -$60.78 million.
Performance
OCUL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
OCUL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | +27.4% | -4185.3% |
| 3 y3 years | +50.6% | +29.2% | -4974.0% |
| 5 y5 years | +213.9% | +76.4% | -6769.6% |
OCUL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.1% | -23.1% | +37.2% | -43.4% | at low |
| 5 y | 5-year | at high | +59.8% | -23.1% | +101.9% | -123.0% | at low |
| alltime | all time | at high | +3390.6% | -23.1% | +3880.4% | -5015.0% | at low |
Ocular Therapeutix Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $22.81 M(-23.1%) | $94.07 M(+5.5%) |
| Jun 2024 | - | $29.66 M(+21.9%) | $89.16 M(+13.1%) |
| Mar 2024 | - | $24.33 M(+40.9%) | $78.86 M(+5.9%) |
| Dec 2023 | $74.49 M(+3.2%) | $17.27 M(-3.5%) | $74.49 M(-2.1%) |
| Sep 2023 | - | $17.90 M(-7.5%) | $76.10 M(-1.1%) |
| Jun 2023 | - | $19.36 M(-3.0%) | $76.92 M(+1.9%) |
| Mar 2023 | - | $19.96 M(+5.7%) | $75.49 M(+4.6%) |
| Dec 2022 | $72.15 M(+7.6%) | $18.88 M(+0.9%) | $72.14 M(+3.2%) |
| Sep 2022 | - | $18.72 M(+4.4%) | $69.94 M(+1.5%) |
| Jun 2022 | - | $17.93 M(+7.9%) | $68.87 M(+1.4%) |
| Mar 2022 | - | $16.62 M(-0.3%) | $67.94 M(+1.3%) |
| Dec 2021 | $67.07 M(+35.6%) | $16.67 M(-5.6%) | $67.07 M(+5.1%) |
| Sep 2021 | - | $17.65 M(+3.9%) | $63.79 M(+8.8%) |
| Jun 2021 | - | $16.99 M(+7.9%) | $58.61 M(+10.8%) |
| Mar 2021 | - | $15.75 M(+17.7%) | $52.92 M(+7.0%) |
| Dec 2020 | $49.47 M(+6.1%) | $13.39 M(+7.3%) | $49.47 M(+1.4%) |
| Sep 2020 | - | $12.48 M(+10.5%) | $48.78 M(-0.9%) |
| Jun 2020 | - | $11.30 M(-8.2%) | $49.23 M(-2.0%) |
| Mar 2020 | - | $12.31 M(-3.0%) | $50.21 M(+7.7%) |
| Dec 2019 | $46.61 M(+96.4%) | $12.69 M(-1.8%) | $46.61 M(+12.8%) |
| Sep 2019 | - | $12.93 M(+5.3%) | $41.33 M(+21.9%) |
| Jun 2019 | - | $12.28 M(+41.1%) | $33.91 M(+25.9%) |
| Mar 2019 | - | $8.71 M(+17.4%) | $26.95 M(+13.6%) |
| Dec 2018 | $23.73 M | $7.41 M(+34.4%) | $23.73 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $5.51 M(+3.8%) | $21.50 M(-8.3%) |
| Jun 2018 | - | $5.31 M(-3.2%) | $23.45 M(-18.3%) |
| Mar 2018 | - | $5.49 M(+5.9%) | $28.69 M(-11.7%) |
| Dec 2017 | $32.51 M(+83.6%) | $5.18 M(-30.6%) | $32.51 M(-1.1%) |
| Sep 2017 | - | $7.47 M(-29.3%) | $32.85 M(+12.1%) |
| Jun 2017 | - | $10.56 M(+13.5%) | $29.30 M(+26.2%) |
| Mar 2017 | - | $9.30 M(+68.3%) | $23.21 M(+31.1%) |
| Dec 2016 | $17.70 M(+36.0%) | $5.53 M(+41.1%) | $17.70 M(+11.3%) |
| Sep 2016 | - | $3.92 M(-12.3%) | $15.91 M(+4.4%) |
| Jun 2016 | - | $4.46 M(+17.7%) | $15.24 M(+8.5%) |
| Mar 2016 | - | $3.79 M(+1.7%) | $14.05 M(+7.9%) |
| Dec 2015 | $13.02 M(+46.3%) | $3.73 M(+14.9%) | $13.02 M(+7.1%) |
| Sep 2015 | - | $3.25 M(-0.7%) | $12.16 M(+7.5%) |
| Jun 2015 | - | $3.27 M(+18.3%) | $11.31 M(+15.8%) |
| Mar 2015 | - | $2.76 M(-3.8%) | $9.77 M(+9.9%) |
| Dec 2014 | $8.89 M(+272.8%) | $2.87 M(+19.5%) | $8.89 M(+34.8%) |
| Sep 2014 | - | $2.40 M(+38.9%) | $6.60 M(+36.2%) |
| Jun 2014 | - | $1.73 M(-8.2%) | $4.84 M(+31.0%) |
| Mar 2014 | - | $1.89 M(+226.7%) | $3.70 M(+55.0%) |
| Dec 2013 | $2.39 M(+11.8%) | $577.00 K(-11.4%) | $2.39 M(+31.9%) |
| Sep 2013 | - | $651.00 K(+11.3%) | $1.81 M(+56.2%) |
| Jun 2013 | - | $585.00 K(+2.1%) | $1.16 M(+102.1%) |
| Mar 2013 | - | $573.00 K | $573.00 K |
| Dec 2012 | $2.13 M | - | - |
FAQ
- What is Ocular Therapeutix annual SGA?
- What is the all time high annual SGA for Ocular Therapeutix?
- What is Ocular Therapeutix annual SGA year-on-year change?
- What is Ocular Therapeutix quarterly SGA?
- What is the all time high quarterly SGA for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly SGA year-on-year change?
- What is Ocular Therapeutix TTM SGA?
- What is the all time high TTM SGA for Ocular Therapeutix?
- What is Ocular Therapeutix TTM SGA year-on-year change?
What is Ocular Therapeutix annual SGA?
The current annual SGA of OCUL is $74.49 M
What is the all time high annual SGA for Ocular Therapeutix?
Ocular Therapeutix all-time high annual SGA is $74.49 M
What is Ocular Therapeutix annual SGA year-on-year change?
Over the past year, OCUL annual SGA has changed by +$2.34 M (+3.25%)
What is Ocular Therapeutix quarterly SGA?
The current quarterly SGA of OCUL is $22.81 M
What is the all time high quarterly SGA for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly SGA is $29.66 M
What is Ocular Therapeutix quarterly SGA year-on-year change?
Over the past year, OCUL quarterly SGA has changed by +$4.91 M (+27.43%)
What is Ocular Therapeutix TTM SGA?
The current TTM SGA of OCUL is -$3.11 B
What is the all time high TTM SGA for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM SGA is -$60.78 M
What is Ocular Therapeutix TTM SGA year-on-year change?
Over the past year, OCUL TTM SGA has changed by -$3.19 B (-4185.29%)